cefoperazone has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, IH; Kim, HJ; Kim, J; Oh, JR; Park, SD; Uh, Y; Yoon, KJ | 1 |
| Baccini, F; Bezzi, M; Caprilli, R; Fiocca, F; Gentile, G; Severi, C; Zippi, M | 1 |
2 other study(ies) available for cefoperazone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
First report of Nocardia farcinica bursitis in a patient with diabetes mellitus.
Topics: Aged; Anti-Bacterial Agents; Bursitis; Cefoperazone; Diabetes Mellitus, Type 2; Humans; Male; Nocardia; Polymerase Chain Reaction; RNA, Ribosomal, 16S; Sequence Analysis, RNA; Sulbactam | 2014 |
Amebic liver abscess, Mirizzi syndrome, and acute hepatic failure.
Topics: Anti-Infective Agents; Barium Radioisotopes; Cefoperazone; Cholecystectomy; Diabetes Mellitus, Type 2; Gallstones; Humans; Liver Abscess, Amebic; Liver Failure, Acute; Male; Metronidazole; Middle Aged; Tomography, X-Ray Computed; Treatment Outcome | 2004 |